Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardio...
Leadership
Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D
Interim CEO & Chairman of the Board
Rhonda L. Hellums
Executive VP, CFO, Secretary & Executive Director
Steven J. Romano M.D.
Executive VP and Chief Research & Development Officer
